Showing results (91-100 of 110) with videos related to
Sort By:
Pageof 11
The European Respiratory Journal|February 19, 2021
Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patientsDieter Munker, Andreas Osterman, Hans Stubbe, et al.Pulmonary Circulation|August 6, 2024
Air travel in patients suffering from pulmonary hypertension-A prospective, multicentre studyAthiththan Yogeswaran, Jan Grimminger, Khodr Tello, et al.Frontiers in Transplantation|July 12, 2024
Case report: Paracorporeal lung assist device for 215 days as a bridge-to-lung transplantation in a patient with bronchopulmonary dysplasia and severe pulmonary hypertensionSebastian G Michel, Maja Hanuna, Joseph Pattathu, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 8, 2024
The role of coronary artery disease in lung transplantation: a propensity-matched analysisEnzo Lüsebrink, Nils Gade, Paula Seifert, et al.Respiratory Research|March 29, 2022
Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertensionChristina A Eichstaedt, Zoe Saßmannshausen, Memoona Shaukat, et al.Nature Communications|July 27, 2021
Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping'David S Fischer, Meshal Ansari, Karolin I Wagner, et al.The European Respiratory Journal|June 29, 2023
Antiviral CD8+ T-cell immune responses are impaired by cigarette smoke and in COPDJie Chen, Xinyuan Wang, Adrian Schmalen, et al.The European Respiratory Journal|October 22, 2021
Temporal trends in pulmonary arterial hypertension: results from the COMPERA registryMarius M Hoeper, Christine Pausch, Ekkehard Grünig, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 17, 2022
Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysisMarius M Hoeper, Christine Pausch, Karen M Olsson, et al.The European Respiratory Journal|November 5, 2021
COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertensionMarius M Hoeper, Christine Pausch, Karen M Olsson, et al.Pageof 11